 Kathleen Simpson
Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 32 | 2025 | 754 | 5.370 |
Why?
| | Fontan Procedure | 12 | 2025 | 180 | 3.660 |
Why?
| | Heart Defects, Congenital | 17 | 2025 | 842 | 2.530 |
Why?
| | Heart-Assist Devices | 17 | 2024 | 552 | 2.060 |
Why?
| | Myocarditis | 5 | 2016 | 100 | 1.600 |
Why?
| | Heart Failure | 18 | 2025 | 2236 | 1.460 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2021 | 385 | 0.870 |
Why?
| | Registries | 9 | 2024 | 2035 | 0.830 |
Why?
| | Postoperative Complications | 4 | 2024 | 2654 | 0.800 |
Why?
| | Lymphopenia | 1 | 2022 | 62 | 0.780 |
Why?
| | Enterovirus | 2 | 2015 | 86 | 0.750 |
Why?
| | Child | 42 | 2025 | 21935 | 0.740 |
Why?
| | Child, Preschool | 25 | 2025 | 11074 | 0.610 |
Why?
| | Kidney Diseases | 1 | 2022 | 408 | 0.590 |
Why?
| | Retrospective Studies | 26 | 2025 | 15657 | 0.580 |
Why?
| | Liver Diseases | 1 | 2021 | 315 | 0.570 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 285 | 0.540 |
Why?
| | Graft Rejection | 5 | 2022 | 624 | 0.530 |
Why?
| | Parvovirus B19, Human | 1 | 2015 | 3 | 0.490 |
Why?
| | Cardiac Myosins | 1 | 2016 | 30 | 0.490 |
Why?
| | Herpesvirus 6, Human | 1 | 2015 | 14 | 0.490 |
Why?
| | Adolescent | 27 | 2025 | 21513 | 0.470 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 136 | 0.470 |
Why?
| | Adenoviridae | 1 | 2015 | 193 | 0.460 |
Why?
| | Stroke | 2 | 2024 | 1120 | 0.420 |
Why?
| | Infant | 15 | 2025 | 9465 | 0.420 |
Why?
| | DNA, Viral | 1 | 2015 | 364 | 0.420 |
Why?
| | Survival Rate | 6 | 2021 | 1972 | 0.400 |
Why?
| | Humans | 49 | 2025 | 137585 | 0.370 |
Why?
| | Myocytes, Cardiac | 1 | 2016 | 526 | 0.360 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2012 | 46 | 0.360 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 316 | 0.350 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 201 | 0.340 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2011 | 43 | 0.340 |
Why?
| | Autoimmunity | 1 | 2016 | 908 | 0.320 |
Why?
| | Heart Valve Prosthesis | 1 | 2011 | 114 | 0.320 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2012 | 323 | 0.320 |
Why?
| | Pulmonary Valve | 1 | 2011 | 97 | 0.320 |
Why?
| | Young Adult | 12 | 2025 | 13209 | 0.320 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2009 | 3 | 0.310 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2011 | 180 | 0.300 |
Why?
| | Surgeons | 2 | 2023 | 297 | 0.300 |
Why?
| | Stroke Volume | 1 | 2012 | 612 | 0.300 |
Why?
| | Autoantibodies | 1 | 2016 | 1496 | 0.290 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 530 | 0.280 |
Why?
| | Ambulatory Care | 1 | 2012 | 546 | 0.280 |
Why?
| | Male | 28 | 2025 | 67762 | 0.270 |
Why?
| | Biopsy | 4 | 2021 | 1129 | 0.270 |
Why?
| | Immunotherapy | 1 | 2011 | 641 | 0.250 |
Why?
| | Female | 28 | 2025 | 73304 | 0.250 |
Why?
| | Enterovirus Infections | 1 | 2009 | 177 | 0.250 |
Why?
| | Time Factors | 7 | 2021 | 6828 | 0.240 |
Why?
| | Treatment Outcome | 12 | 2024 | 10811 | 0.240 |
Why?
| | Cardiac Surgical Procedures | 1 | 2011 | 530 | 0.240 |
Why?
| | Population Surveillance | 2 | 2021 | 482 | 0.240 |
Why?
| | Liver | 1 | 2013 | 1943 | 0.230 |
Why?
| | Glomerular Filtration Rate | 2 | 2024 | 746 | 0.210 |
Why?
| | Waiting Lists | 4 | 2025 | 266 | 0.210 |
Why?
| | American Heart Association | 2 | 2023 | 306 | 0.200 |
Why?
| | Calcineurin Inhibitors | 1 | 2022 | 72 | 0.190 |
Why?
| | Muscular Dystrophies | 1 | 2022 | 36 | 0.190 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2023 | 108 | 0.190 |
Why?
| | Heart | 2 | 2016 | 655 | 0.190 |
Why?
| | Cardiovascular System | 1 | 2023 | 137 | 0.180 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2828 | 0.180 |
Why?
| | Device Approval | 1 | 2021 | 21 | 0.180 |
Why?
| | Practice Patterns, Physicians' | 2 | 2021 | 1313 | 0.170 |
Why?
| | Cardiomyopathies | 2 | 2015 | 350 | 0.170 |
Why?
| | Transplant Recipients | 1 | 2022 | 184 | 0.170 |
Why?
| | Nutritional Status | 1 | 2023 | 350 | 0.170 |
Why?
| | Dyslipidemias | 1 | 2022 | 176 | 0.160 |
Why?
| | Echocardiography | 3 | 2016 | 642 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 1 | 2022 | 665 | 0.160 |
Why?
| | Patient Selection | 2 | 2021 | 696 | 0.160 |
Why?
| | Follow-Up Studies | 5 | 2024 | 5131 | 0.160 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 32 | 0.150 |
Why?
| | Heart Diseases | 1 | 2022 | 346 | 0.150 |
Why?
| | Ventricular Function | 2 | 2016 | 61 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 617 | 0.140 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 11 | 0.140 |
Why?
| | Consensus | 1 | 2021 | 683 | 0.140 |
Why?
| | Referral and Consultation | 1 | 2023 | 786 | 0.140 |
Why?
| | Kidney Failure, Chronic | 1 | 2023 | 570 | 0.140 |
Why?
| | Immunosuppressive Agents | 1 | 2022 | 890 | 0.140 |
Why?
| | Blood Group Incompatibility | 1 | 2017 | 15 | 0.140 |
Why?
| | Kidney Transplantation | 1 | 2023 | 708 | 0.130 |
Why?
| | Models, Statistical | 1 | 2021 | 669 | 0.130 |
Why?
| | Risk Factors | 7 | 2025 | 10388 | 0.130 |
Why?
| | Treatment Failure | 2 | 2021 | 356 | 0.130 |
Why?
| | Adult | 9 | 2025 | 37929 | 0.130 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 889 | 0.120 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1430 | 0.120 |
Why?
| | Seizures | 1 | 2018 | 426 | 0.110 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 124 | 0.110 |
Why?
| | Infant, Newborn | 4 | 2019 | 6079 | 0.110 |
Why?
| | Databases, Factual | 1 | 2019 | 1357 | 0.110 |
Why?
| | Assisted Circulation | 1 | 2013 | 26 | 0.110 |
Why?
| | Biomarkers | 3 | 2021 | 4149 | 0.100 |
Why?
| | Liver Function Tests | 1 | 2013 | 114 | 0.100 |
Why?
| | Prospective Studies | 3 | 2021 | 7604 | 0.100 |
Why?
| | Echocardiography, Doppler | 1 | 2013 | 108 | 0.100 |
Why?
| | Phenotype | 1 | 2021 | 3196 | 0.100 |
Why?
| | Myocardium | 1 | 2018 | 1002 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1062 | 0.100 |
Why?
| | United States | 5 | 2024 | 14841 | 0.090 |
Why?
| | Cohort Studies | 1 | 2022 | 5742 | 0.090 |
Why?
| | Acute Disease | 2 | 2014 | 1007 | 0.090 |
Why?
| | Age Factors | 4 | 2021 | 3295 | 0.090 |
Why?
| | Outpatients | 1 | 2014 | 396 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2015 | 3556 | 0.090 |
Why?
| | Incidence | 3 | 2024 | 2804 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2011 | 327 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2671 | 0.070 |
Why?
| | Quality of Life | 2 | 2022 | 2892 | 0.070 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2024 | 301 | 0.070 |
Why?
| | Heart Ventricles | 1 | 2012 | 788 | 0.070 |
Why?
| | Logistic Models | 2 | 2024 | 2074 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 629 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2009 | 1483 | 0.060 |
Why?
| | Cardiotoxicity | 1 | 2023 | 26 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2691 | 0.050 |
Why?
| | Nutritional Support | 1 | 2023 | 34 | 0.050 |
Why?
| | Allografts | 1 | 2022 | 146 | 0.040 |
Why?
| | Protein-Losing Enteropathies | 1 | 2021 | 10 | 0.040 |
Why?
| | Fasting | 1 | 2023 | 281 | 0.040 |
Why?
| | Perioperative Care | 1 | 2023 | 178 | 0.040 |
Why?
| | Medical Oncology | 1 | 2023 | 289 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2023 | 195 | 0.040 |
Why?
| | North America | 1 | 2021 | 313 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4030 | 0.040 |
Why?
| | Pulsatile Flow | 1 | 2017 | 60 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2844 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1113 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2018 | 565 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1468 | 0.030 |
Why?
| | Blood Circulation | 1 | 2015 | 41 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1509 | 0.030 |
Why?
| | Risk Assessment | 1 | 2024 | 3457 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1266 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2014 | 206 | 0.030 |
Why?
| | Chagas Cardiomyopathy | 1 | 2014 | 24 | 0.030 |
Why?
| | Endocarditis, Bacterial | 1 | 2014 | 41 | 0.030 |
Why?
| | Shock, Cardiogenic | 1 | 2014 | 63 | 0.030 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2013 | 99 | 0.030 |
Why?
| | Animals | 2 | 2014 | 36940 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1178 | 0.020 |
Why?
| | Virus Diseases | 1 | 2014 | 212 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1587 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2734 | 0.020 |
Why?
| | Heart Rate | 1 | 2013 | 822 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2992 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2031 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4295 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 5778 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 33479 | 0.010 |
Why?
|
|
Simpson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|